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*Neisseria gonorrhoeae* is a Gram-negative, betaproteobacterium that is the etiological agent responsible for the sexually transmitted infection gonorrhea. In 2008, the World Health Organization estimated 106 million new gonorrhea cases worldwide ([@B1]), and the Centers for Disease Control and Prevention (CDC) reported over 300,000 cases in 2012, making it the second most common notifiable infection in the United States ([@B2]). The emergence of gonococcal resistance to former first-line antibiotics (e.g., penicillins, tetracyclines, fluoroquinolones, and cephalosporins) has been facilitated by both plasmid- and chromosome-mediated mechanisms ([@B3]). In response to the recent emergence of decreased susceptibility to third-generation cephalosporins, the CDC currently recommends the dual-use of ceftriaxone with either azithromycin or doxycycline as treatment for uncomplicated gonorrhea ([@B4]).

To better understand the mechanisms associated with antibiotic resistance, we sequenced the complete genomes of three laboratory reference strains with varying degrees of antibiotic susceptibility. Gonococcal strain FA19 is a wild-type strain that was isolated in 1962 from a patient with a disseminated gonococcal infection, and is highly susceptible to penicillin, tetracycline, erythromycin, chloramphenicol, and rifampin ([@B5]) (<https://www.broadinstitute.org/annotation/genome/neisseria_gonorrhoeae/GenomeDescriptions.html#Strain_fa19>). Strain FA6140 was isolated in 1983 from an outbreak of penicillin-resistant gonorrhea in Durham, NC, and it exhibits chromosomally mediated resistance to penicillin, tetracycline, and erythromycin ([@B6]). Lastly, strain 35/02 was isolated in 2002 in Sweden, and it exhibits chromosomally mediated resistance to penicillin and reduced susceptibility to the extended-spectrum cephalosporins, cefixime and ceftriaxone ([@B7]). Moreover, 35/02 also contains a mosaic *penA* allele with 58 mutations relative to the *penA* gene from FA19 ([@B7]); mosaic *penA* alleles are strongly associated with reduced cefixime and ceftriaxone susceptibility in clinical samples ([@B8]).

Whole-genome sequencing was conducted using the PacBio RSII platform (Pacific Biosciences, Menlo Park, CA) with P5-C3 chemistry. A single single-molecule real-time (SMRT) cell was used to sequence FA19 (mean coverage of 119-fold), while FA6140 and 35/02 were each sequenced using two SMRT cells (mean coverage of 309-fold and 262-fold, respectively). *De novo* assembly of the genomes was conducted using the hierarchical genome assembly process (HGAP3, SMRTAnalysis 2.3.0) workflow, which included consensus polishing using Quiver ([@B9]). Single, closed contigs were assembled for each sequence, and the following genome length and G+C content data were obtained: FA19 (2,232,367 bp, 52.4% G+C content), FA6140 (2,168,698 bp, 52.6% G+C content), and 35/02 (2,173,235 bp, 52.6% G+C content). The genomes were annotated using Prokka version 1.11 ([@B10]), and a total of 2,289, 2,230, and 2,228 coding sequences were annotated in FA19, FA6140, and 35/02, respectively. A comparative analysis of these genomes will be reported in a future publication.
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The complete genome sequences for *N. gonorrhoeae* strains FA19, FA6140, and 35/02 have been deposited in GenBank under the accession numbers [CP012026](CP012026), [CP012027](CP012027), and [CP012028](CP012028), respectively.
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